Macrobid vs. Clindamycin

See how Macrobid and Clindamycin compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Macrobid is a narrow-spectrum antibiotic reserved for uncomplicated bladder infections, while clindamycin treats serious infections across the skin, lungs, bones, and abdomen.

  • Clindamycin carries a boxed warning for C. difficile-associated diarrhea and colitis, a risk not associated with Macrobid.

  • Macrobid must be avoided in significant kidney impairment, while clindamycin's dose and schedule vary widely depending on infection severity and route.

Macrobid vs. Clindamycin Drug Summary

Macrobid

Macrobid is a urinary anti-infective in the nitrofuran class, used to treat uncomplicated urinary tract infections caused by susceptible bacteria like E. coli. It's taken as an oral capsule twice a day for seven days and works by concentrating in urine rather than the bloodstream.

Clindamycin

Clindamycin is a lincosamide antibiotic used for serious infections caused by anaerobic bacteria, streptococci, staphylococci, and other susceptible organisms, including skin, respiratory, and abdominal infections. It comes in oral, IV, and topical forms, with oral capsules typically taken every six hours.

Macrobid vs. Clindamycin Side Effects

Macrobid

Most common
nausea (up to 8%)
vomiting (up to 1%)
headache (up to 6%)
flatulence (up to 1.5%)

Clindamycin

Most common
nausea (up to 10%)
vomiting (up to 6%)
diarrhea (up to 20%)
skin rash (up to 10%)

Macrobid vs. Clindamycin Dosage

Macrobid

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg every 12 hours Days 1-7
Maximum dose 100 mg every 12 hours Same as starting
Dose changes None Fixed dose

Clindamycin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 150 mg every 6 hours At the start
Maximum dose up to 4800 mg/day IV If needed
Dose changes 6 increases As tolerated

Macrobid vs. Clindamycin Indications

Macrobid

Macrobid is FDA-approved specifically for acute, uncomplicated bladder infections (cystitis) caused by susceptible bacteria such as E. coli or S. saprophyticus. It is not approved for kidney infections or infections that have spread beyond the bladder. Doctors sometimes prescribe it off-label at low doses for long-term prevention of recurrent UTIs.

  • Acute uncomplicated UTI (cystitis)

  • Caused by susceptible E. coli or S. saprophyticus

  • Off-label: long-term UTI prevention

  • Not approved for kidney infections (pyelonephritis)

Clindamycin

Clindamycin treats serious infections from anaerobic bacteria as well as susceptible strep, staph, and pneumococcal organisms, including skin, respiratory, bone, joint, and abdominal infections. Topical and vaginal forms are also approved for acne and bacterial vaginosis. It's generally reserved for infections where less toxic antibiotics aren't appropriate, due to its C. diff risk.

  • Serious anaerobic bacterial infections

  • Skin, respiratory, bone, and joint infections

  • Acne (topical) and bacterial vaginosis (vaginal)

  • Off-label: penicillin-allergy surgical prophylaxis

Macrobid vs. Clindamycin Pros and Cons

Macrobid

Macrobid offers a targeted, short-course option for simple UTIs with minimal systemic exposure, but it isn't built for infections beyond the bladder. Coverage is usually straightforward for a short prescription, though it's unsuitable for patients with reduced kidney function.

Pros

  • Lower risk of C. diff-associated colitis than broad-spectrum antibiotics

  • Simple twice-daily, 7-day course for most UTIs

  • Long track record of reliable effectiveness against E. coli

  • Minimal systemic absorption limits some systemic side effects

Cons

  • Not usable in significant kidney impairment (CrCl under 60)

  • Risk of rare but serious lung and liver reactions with prolonged use

  • Not effective for infections outside the urinary tract

  • Contraindicated near labor and delivery at term

Clindamycin

Clindamycin covers a much wider range of serious bacterial infections and comes in multiple formulations, but that breadth comes with real risks like C. diff colitis. It's typically reserved for cases where narrower antibiotics won't work.

Pros

  • Works against a much broader range of bacteria and body sites

  • Available in oral, IV, topical, and vaginal forms for flexible use

  • Useful alternative for patients with a penicillin allergy

  • Can treat infections that have spread beyond one body system

Cons

  • Carries a boxed warning for C. diff-associated diarrhea and colitis

  • Oral capsules must be taken with plenty of fluid to avoid esophageal irritation

  • Not effective for meningitis due to poor CNS penetration

  • More frequent dosing schedule, every 6 to 8 hours, for oral and IV forms

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.